Therefore, interactions between trials occur (a) at the level of each COG (which ultimately proposes the trial to be carried out among the member institutions) (figure 2a), (b) type of disease, since the treatment discovery is typically a disease-oriented process (i.e. breast cancer, gastrointestinal cancer, gynecologic cancer, etc).
Finally, the report discusses a number of issues that must be taken into account when mixing modes is deemed necessary or unavoidable within or between trials, including considerations of the risk of mixing at different levels within a clinical trial program and mixing between different types of platforms.
They consist of 6 consecutive trials of 2 min at constant speed, with increasing speed between each trial (4, 10, 16, 22, 28, 34 and 40 rpm).
Subsequent analyses (see below) determined that 82% of variation between trials is due to differences in the ambient environmental temperature at which the exercise was performed.
Interval between trials and within trials (exchange of roles) had a length of 15 seconds.
It accounted for the correlation of outcome data reported at different time points within a trial and allowed the estimation of the variance of treatment effects between trials.
Subjects performed three trials with a minimum of three minutes between trials to minimize fatigue.
Our analyses have several limitations, as many parameters (post-first line therapies, treatment with cdk4/6 inhibitors at a later stage…) will ultimately influence the OS differences between the two arms of each trial and between trials.
The variation of effects within trials and between trials is included in the model [5],[5]].
There was no difference between trial arms in the number of tablets returned at the end of the study (mean: 37 tablets in the vitamin B-12 arm and 39 tablets in the placebo arm).
